Research summary, narrative review, 2016

Brain Tumors, Interventionists, and Radiation: How Real Is the Risk?

Endovascular Today. 2016

Open the source page

In plain language

This review by medical physicists argues that evidence linking occupational radiation to brain tumors in interventionists is inconclusive. Reported operator head doses vary greatly, and the case series rely on self-report. The authors call for more rigorous dosimetry and epidemiology.

At a glance

Type of study
Narrative review
Who was studied
Interventional cardiologists, Interventional radiologists, Other physicians
Summary based on
a web page

What it found

  • Reported operator doses from fluoroscopy-guided procedures vary widely, so typical operator exposure is unclear.

  • An updated case series reported 31 interventionists with brain tumors, mostly left-sided, but it relies on self-reported data.

    Key figures: 22 of 26 cases left-sided

  • The authors note that other occupations also show increased glioma incidence and that left-sided tumors may be diagnosed earlier, suggesting factors other than radiation may be involved.

  • A hanging lead shield was associated with lower 3-month cumulative head dose in a cited study.

    Key figures: 2.77 mSv without shield vs 0.22 to 1.16 mSv with shield

  • In a cited survey of cath lab professionals, some left cath lab work because of radiation concerns, while reported cancer diagnoses were low.

    Key figures: 10.6% stopped working; 2.2% diagnosed with cancer; n=615

Limits to keep in mind

Narrative review by two medical physicists without systematic search methods; it summarizes heterogeneous dosimetry studies and weak epidemiologic evidence, and its interpretation (e.g., that career decisions reflected fear) is the authors' opinion.

How this summary was made

ORSIF prepared this summary with AI assistance from a web page of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.